位置:首页 > 蛋白库 > TPOR_MOUSE
TPOR_MOUSE
ID   TPOR_MOUSE              Reviewed;         625 AA.
AC   Q08351; A6H8H6; Q8BRX0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Thrombopoietin receptor;
DE            Short=TPO-R;
DE   AltName: Full=Myeloproliferative leukemia protein;
DE   AltName: Full=Proto-oncogene c-Mpl;
DE   AltName: CD_antigen=CD110;
DE   Flags: Precursor;
GN   Name=Mpl; Synonyms=Tpor;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8334987; DOI=10.1002/j.1460-2075.1993.tb05925.x;
RA   Skoda R.C., Seldin D.C., Chiang M.K., Peichel C.L., Vogt T.F., Leder P.;
RT   "Murine c-mpl: a member of the hematopoietic growth factor receptor
RT   superfamily that transduces a proliferative signal.";
RL   EMBO J. 12:2645-2653(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=ICFW; TISSUE=Fetal liver;
RX   PubMed=8397366;
RA   Vigon I., Florindo C., Fichelson S., Guenet J.-L., Mattei M.-G., Souyri M.,
RA   Cosman D., Gisselbrecht S.;
RT   "Characterization of the murine Mpl proto-oncogene, a member of the
RT   hematopoietic cytokine receptor family: molecular cloning, chromosomal
RT   location and evidence for a function in cell growth.";
RL   Oncogene 8:2607-2615(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Aorta, and Vein;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=15210714; DOI=10.1074/jbc.m401386200;
RA   Coers J., Ranft C., Skoda R.C.;
RT   "A truncated isoform of c-Mpl with an essential C-terminal peptide targets
RT   the full-length receptor for degradation.";
RL   J. Biol. Chem. 279:36397-36404(2004).
RN   [7]
RP   INDUCTION.
RX   PubMed=22284746; DOI=10.1111/j.1538-7836.2012.04643.x;
RA   Tracey C.J., Pan X., Catterson J.H., Harmar A.J., Hussain M.M.,
RA   Hartley P.S.;
RT   "Diurnal expression of the thrombopoietin gene is regulated by CLOCK.";
RL   J. Thromb. Haemost. 10:662-669(2012).
RN   [8]
RP   ALTERNATIVE SPLICING.
RX   PubMed=25468569; DOI=10.1182/blood-2014-08-593392;
RA   Xiao N., Laha S., Das S.P., Morlock K., Jesneck J.L., Raffel G.D.;
RT   "Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells
RT   through alternative splicing of c-Mpl.";
RL   Blood 125:941-948(2015).
CC   -!- FUNCTION: Receptor for thrombopoietin that acts as a primary regulator
CC       of megakaryopoiesis and platelet production. May represent a regulatory
CC       molecule specific for TPO-R-dependent immune responses.
CC       {ECO:0000269|PubMed:15210714}.
CC   -!- FUNCTION: [Isoform Mpl-tr]: Acts as an inhibitor of thrombopoietin
CC       signaling by promoting protein down-regulation of full-length isoform
CC       Mpl-fl. {ECO:0000269|PubMed:15210714}.
CC   -!- SUBUNIT: Homodimer. Interacts with ATXN2L.
CC       {ECO:0000250|UniProtKB:P40238}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P40238}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P40238}. Cell surface
CC       {ECO:0000250|UniProtKB:P40238}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Mpl-fl {ECO:0000303|PubMed:15210714}; Synonyms=Mpl-full-length
CC       {ECO:0000303|PubMed:15210714};
CC         IsoId=Q08351-1; Sequence=Displayed;
CC       Name=Mpl-tr {ECO:0000303|PubMed:15210714}; Synonyms=Mpl-truncated
CC       {ECO:0000303|PubMed:15210714};
CC         IsoId=Q08351-2; Sequence=VSP_059621, VSP_059622;
CC   -!- INDUCTION: Expression in the bone marrow displays diurnal rhythmicity
CC       (a circadian rhythm that is synchronized with the day/night cycle).
CC       {ECO:0000269|PubMed:22284746}.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- PTM: Ubiquitination at Lys-544 and Lys-564 targets MPL for degradation
CC       by both the lysosomal and proteasomal pathways. The E3 ubiquitin-
CC       protein ligase CBL significantly contributes to this ubiquitination (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform Mpl-tr]: Rbm15 regulates the production of
CC       isoform Mpl-tr. {ECO:0000269|PubMed:25468569}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z22649; CAA80365.1; -; mRNA.
DR   EMBL; Z22657; CAA80372.1; -; Genomic_DNA.
DR   EMBL; X73677; CAA52031.1; -; mRNA.
DR   EMBL; AK041166; BAC30846.1; -; mRNA.
DR   EMBL; AL627212; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146613; AAI46614.1; -; mRNA.
DR   CCDS; CCDS18552.1; -. [Q08351-1]
DR   PIR; S35317; S35317.
DR   PIR; S37622; S37622.
DR   RefSeq; NP_001116421.1; NM_001122949.2.
DR   RefSeq; NP_001272425.1; NM_001285496.1.
DR   RefSeq; NP_001272426.1; NM_001285497.1.
DR   RefSeq; NP_034953.2; NM_010823.3. [Q08351-1]
DR   AlphaFoldDB; Q08351; -.
DR   BioGRID; 201478; 2.
DR   IntAct; Q08351; 1.
DR   STRING; 10090.ENSMUSP00000099732; -.
DR   ChEMBL; CHEMBL1075309; -.
DR   GlyGen; Q08351; 1 site.
DR   iPTMnet; Q08351; -.
DR   PhosphoSitePlus; Q08351; -.
DR   MaxQB; Q08351; -.
DR   PaxDb; Q08351; -.
DR   PRIDE; Q08351; -.
DR   ProteomicsDB; 259503; -. [Q08351-1]
DR   ABCD; Q08351; 3 sequenced antibodies.
DR   Antibodypedia; 2379; 324 antibodies from 31 providers.
DR   DNASU; 17480; -.
DR   Ensembl; ENSMUST00000102671; ENSMUSP00000099732; ENSMUSG00000006389. [Q08351-1]
DR   GeneID; 17480; -.
DR   KEGG; mmu:17480; -.
DR   UCSC; uc008uke.3; mouse. [Q08351-1]
DR   CTD; 4352; -.
DR   MGI; MGI:97076; Mpl.
DR   VEuPathDB; HostDB:ENSMUSG00000006389; -.
DR   eggNOG; ENOG502RYN1; Eukaryota.
DR   GeneTree; ENSGT00940000161225; -.
DR   HOGENOM; CLU_029931_1_0_1; -.
DR   InParanoid; Q08351; -.
DR   OMA; LPFGTRY; -.
DR   OrthoDB; 253180at2759; -.
DR   TreeFam; TF336573; -.
DR   BioGRID-ORCS; 17480; 2 hits in 75 CRISPR screens.
DR   ChiTaRS; Mpl; mouse.
DR   PRO; PR:Q08351; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q08351; protein.
DR   Bgee; ENSMUSG00000006389; Expressed in blood and 39 other tissues.
DR   ExpressionAtlas; Q08351; baseline and differential.
DR   Genevisible; Q08351; MM.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043005; C:neuron projection; ISO:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISO:MGI.
DR   GO; GO:0031965; C:nuclear membrane; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0038164; F:thrombopoietin receptor activity; ISS:UniProtKB.
DR   GO; GO:1990960; P:basophil homeostasis; ISO:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0060216; P:definitive hemopoiesis; IMP:MGI.
DR   GO; GO:1990959; P:eosinophil homeostasis; ISO:MGI.
DR   GO; GO:0030097; P:hemopoiesis; IBA:GO_Central.
DR   GO; GO:0048872; P:homeostasis of number of cells; IMP:MGI.
DR   GO; GO:0035702; P:monocyte homeostasis; ISO:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:MGI.
DR   GO; GO:0001780; P:neutrophil homeostasis; ISO:MGI.
DR   GO; GO:0030220; P:platelet formation; IGI:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:MGI.
DR   GO; GO:0050671; P:positive regulation of lymphocyte proliferation; ISO:MGI.
DR   GO; GO:1905221; P:positive regulation of platelet formation; ISO:MGI.
DR   GO; GO:0032642; P:regulation of chemokine production; IMP:MGI.
DR   GO; GO:2000035; P:regulation of stem cell division; IMP:MGI.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; IMP:MGI.
DR   GO; GO:0038163; P:thrombopoietin-mediated signaling pathway; IDA:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   SMART; SM00060; FN3; 2.
DR   SUPFAM; SSF49265; SSF49265; 3.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Glycoprotein; Golgi apparatus;
KW   Isopeptide bond; Membrane; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..625
FT                   /note="Thrombopoietin receptor"
FT                   /id="PRO_0000010988"
FT   TOPO_DOM        26..482
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        483..504
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        505..625
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          178..270
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          383..479
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   MOTIF           465..469
FT                   /note="WSXWS motif"
FT   MOTIF           519..527
FT                   /note="Box 1 motif"
FT   CARBOHYD        117
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        544
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P40238"
FT   CROSSLNK        564
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P40238"
FT   VAR_SEQ         428..457
FT                   /note="VLEPSLGARGGTLELRPRARYSLQLRARLN -> ETEACFVALASRPTPGPR
FT                   PVPQRHCSPKSF (in isoform Mpl-tr)"
FT                   /id="VSP_059621"
FT   VAR_SEQ         458..625
FT                   /note="Missing (in isoform Mpl-tr)"
FT                   /id="VSP_059622"
FT   CONFLICT        1..7
FT                   /note="Missing (in Ref. 2; CAA52031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        99
FT                   /note="D -> V (in Ref. 2; CAA52031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="P -> PVRTSPAGE (in Ref. 2; CAA52031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        241
FT                   /note="G -> S (in Ref. 1; CAA80365, 2; CAA52031 and 5;
FT                   AAI46614)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   625 AA;  69788 MW;  87836E6EA4688ED7 CRC64;
     MPSWALFMVT SCLLLALPNQ AQVTSQDVFL LALGTEPLNC FSQTFEDLTC FWDEEEAAPS
     GTYQLLYAYR GEKPRACPLY SQSVPTFGTR YVCQFPAQDE VRLFFPLHLW VKNVSLNQTL
     IQRVLFVDSV GLPAPPRVIK ARGGSQPGEL QIHWEAPAPE ISDFLRHELR YGPTDSSNAT
     APSVIQLLST ETCCPTLWMP NPVPVLDQPP CVHPTASQPH GPAPFLTVKG GSCLVSGLQA
     GKSYWLQLRS QPDGVSLRGS WGPWSFPVTV DLPGDAVTIG LQCFTLDLKM VTCQWQQQDR
     TSSQGFFRHS RTRCCPTDRD PTWEKCEEEE PRPGSQPALV SRCHFKSRND SVIHILVEVT
     TAQGAVHSYL GSPFWIHQAV LLPTPSLHWR EVSSGRLELE WQHQSSWAAQ ETCYQLRYTG
     EGREDWKVLE PSLGARGGTL ELRPRARYSL QLRARLNGPT YQGPWSAWSP PARVSTGSET
     AWITLVTALL LVLSLSALLG LLLLKWQFPA HYRRLRHALW PSLPDLHRVL GQYLRDTAAL
     SPSKATVTDS CEEVEPSLLE ILPKSSESTP LPLCPSQPQM DYRGLQPCLR TMPLSVCPPM
     AETGSCCTTH IANHSYLPLS YWQQP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024